AHG · Akso Health Group · Metrics
Market Cap
$1.15B
Shares
856.70M
Volume · Nov 12
1465
Avg daily vol (3M)
107.4K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
AHG metrics
53 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$1.35
Market cap
$1.15B
Price action
23 metricsPrice change (1W)
+1.5%
Price change (30D)
-0.7%
Price change (3M)
-8.2%
Price change (6M)
-30.1%
Price change (YTD)
-17.7%
Price change (1Y)
-13.5%
Trailing year
Price change (5Y)
-62.5%
52-week high
$2.50
52-week low
$0.69
Change from 52-week high
-46.0%
Change from 52-week low
+95.4%
Annualized volatility
97.9%
Annualized volatility (3M)
115.3%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.0
RSI (14D)
56.3
Price vs SMA 50
+25.3%
Price vs SMA 200
-10.3%
Avg volume (3M)
107,395
Relative volume
0.1
Average dollar volume
$99,633
Company
3 metricsSector
Healthcare
Industry
Medical Distribution
Shares outstanding
856.70M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
6.4
reciprocal yield 15.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-0.1%
Operating margin
-149.7%
Trailing 12 months
Net margin
-135.0%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-6.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-93.8%
Shares change YoY
+153.5%
Year over year · more shares
Revenue CAGR (3Y)
+1.6%
Revenue CAGR (5Y)
+51.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-10.3%
Return on assets
-9.8%
Debt / equity
—
Current ratio
21.8
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
21.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$170,572
Total assets
$189.63M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
$260,658
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
11
13F filer change QoQ
+5
Institutional ownership
0.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+23.9%
Holder tenure
8.1
Price vs estimated holder cost
-23.8%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.0%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
45 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—